Skip to search formSkip to main contentSkip to account menu

T 3762

Known as: T-3762 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Abstract We studied the effect of pazufloxacin mesilate (T-3762), a new fluoroquinolone for intravenous administration, on the… 
Review
2000
Review
2000
Toyama Chemical Co Ltd is developing pazufloxacin (T-3761), an orally active synthetic quinolone antibiotic, which is awaiting… 
1999
1999
T-3762 is an injectable new quinolone with a broad spectrum of antibacterial activity. Pazufloxacin (T-3761) is an active form of… 
1998
1998
A teratogenicity study of T-3762, an injectable new quinolone antibacterial agent, was conducted in Sprague-Dawley rats to… 
1998
1998
Single dose intravenous toxicity studies of T-3762, a novel parenteral quinolone antimicrobial agent, were conducted in rats… 
1998
1998
A three months intravenous repeated dose toxicity study of T-3762, a novel parenteral quinolone antibacterial agent, was carried… 
1996
1996
The bactericidal activity of antibacterial agents against intracellular bacteria using aSalmonella-lined macrophage model (TtT/M…